The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer

Background: Cabazitaxel is a second-generation taxane that is approved for use with concomitant low dose daily prednisone in metastatic castration resistant prostate cancer (mCRPC) after docetaxel failure. Since the role of daily corticosteroids in improving cabazitaxel efficacy or ameliorating its...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Autores principales: Buonerba, Carlo, Sonpavde, Guru, Vitrone, Francesca, Bosso, Davide, Puglia, Livio, Izzo, Michela, Iaccarino, Simona, Scafuri, Luca, Muratore, Margherita, Foschini, Francesca, Mucci, Brigitta, Tortora, Vincenzo, Pagliuca, Martina, Ribera, Dario, Riccio, Vittorio, Morra, Rocco, Mosca, Mirta, Cesarano, Nicola, Di Costanzo, Ileana, De Placido, Sabino, Di Lorenzo, Giuseppe
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604196/
https://ncbi.nlm.nih.gov/pubmed/28928853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.20040
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares